KEY TAKEAWAY: Net price hikes in the U.S. last year created $8.7 billion in net income for top pharma companies, equivalent to all of the sector’s earnings growth according a new report from Credit Suisse.  Profits aren’t enough for pharma companies as The Street wants to see “growth”.